|

CD146/HER2 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Essen Biotech1

Indications

  • Sarcomas, Germinoblastic1
  • Sarcoma, Kaposi1
  • Sarcoma, Synovial1
  • Sarcoma of Bone and Connective Tissue1
  • Sarcoma Metastatic1

Other1 trial

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.